3.83 USD
-0.01 (-0.26%)
3.85 USD
+0.02 (+0.52%)
We assign a fundamental rating of 3 out of 10 to LFMD. LFMD was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMD have multiple concerns. LFMD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year LFMD has reported negative net income.
LFMD had a positive operating cash flow in the past year.
In the past 5 years LFMD always reported negative net income.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
LFMD's Return On Assets of -12.28% is in line compared to the rest of the industry. LFMD outperforms 57.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD's Gross Margin of 87.57% is amongst the best of the industry. LFMD outperforms 94.29% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
The Profit Margin and Operating Margin are not available for LFMD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LFMD has been increased compared to 1 year ago.
Compared to 5 years ago, LFMD has more shares outstanding
The debt/assets ratio for LFMD has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.06, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
LFMD has a Altman-Z score (-0.06) which is in line with its industry peers.
LFMD has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMD would need 2.31 years to pay back of all of its debts.
LFMD has a better Debt to FCF ratio (2.31) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | -0.06 |
ROIC/WACCN/A
WACC10.66%
2.3 Liquidity
A Current Ratio of 0.77 indicates that LFMD may have some problems paying its short term obligations.
The Current ratio of LFMD (0.77) is worse than 80.00% of its industry peers.
A Quick Ratio of 0.72 indicates that LFMD may have some problems paying its short term obligations.
LFMD's Quick ratio of 0.72 is on the low side compared to the rest of the industry. LFMD is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 78.13% over the past year.
The Revenue has grown by 39.27% in the past year. This is a very strong growth!
The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
The Earnings Per Share is expected to grow by 18.36% on average over the next years. This is quite good.
LFMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5Y18.36%
Revenue Next Year23.06%
Revenue Next 2Y20.09%
Revenue Next 3Y19.18%
Revenue Next 5Y3.16%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 16.09 indicates a correct valuation of LFMD.
LFMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. LFMD is cheaper than 85.71% of the companies in the same industry.
LFMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.09 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 74.29% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LFMD is valued a bit cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.52 | ||
| EV/EBITDA | 19.19 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 40.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.23%
EPS Next 3Y40.83%
5. Dividend
5.1 Amount
LFMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.83
-0.01 (-0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners53.98%
Inst Owner Change-14.42%
Ins Owners18.82%
Ins Owner Change2.51%
Market Cap184.38M
Revenue(TTM)212.45M
Net Income(TTM)-9.03M
Analysts81.43
Price Target13.13 (242.82%)
Short Float %11.47%
Short Ratio3.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)0%
PT rev (3m)2.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-79.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-89.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.09 | ||
| P/S | 0.75 | ||
| P/FCF | 27.52 | ||
| P/OCF | 9.47 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.19 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.24
Fwd EY6.21%
FCF(TTM)0.14
FCFY3.63%
OCF(TTM)0.4
OCFY10.56%
SpS5.1
BVpS-0.04
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -0.06 |
F-Score5
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5Y18.36%
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year23.06%
Revenue Next 2Y20.09%
Revenue Next 3Y19.18%
Revenue Next 5Y3.16%
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.54%
EBIT Next 3Y69.78%
EBIT Next 5Y43.22%
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFMD.
What is the valuation status of LIFEMD INC (LFMD) stock?
ChartMill assigns a valuation rating of 5 / 10 to LIFEMD INC (LFMD). This can be considered as Fairly Valued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 2 / 10.
What is the financial health of LIFEMD INC (LFMD) stock?
The financial health rating of LIFEMD INC (LFMD) is 2 / 10.
Can you provide the dividend sustainability for LFMD stock?
The dividend rating of LIFEMD INC (LFMD) is 0 / 10 and the dividend payout ratio is -34.38%.